Literature DB >> 2208308

Interleukin-2 mRNA expression, lymphokine production and DNA synthesis in glutathione-depleted T cells.

H Gmünder1, S Roth, H P Eck, H Gallas, S Mihm, W Dröge.   

Abstract

The stimulation of DNA synthesis in lymphocyte populations was previously shown to depend strongly on the intracellular glutathione (GSH) level. Since T cell growth is known to depend on interleukin 2 (IL-2), the experiments in this report were designed to determine whether intracellular GSH depletion may inhibit IL-2 production or the IL-2 dependent DNA synthesis. Our experiments revealed that IL-2 production and DNA synthesis of mitogenically stimulated splenic T cells have indeed different requirements for GSH. The addition of relatively high concentrations of GSH (5 mM) to cultures of concanavalin A (Con A)-stimulated splenic T cells was found to augment strongly the DNA synthesis but inhibited the production of IL-2. Moderate intracellular GSH levels, however, are apparently not inhibitory for IL-2 production, since intracellular GSH depletion by cysteine starvation or by graded concentrations of DL-buthionine sulfoximine (BSO) had virtually no effect on IL-2-specific mRNA expression and the production of T cell growth factor (TCGF). The DNA synthesis activity, in contrast, was strongly suppressed after GSH depletion with either method. As in cultures of splenic T cells, GSH depletion had no substantial effect on the induction of IL-2 mRNA and TCGF production in several mitogenically stimulated T cell clones. Taken together, our experiments suggest that complex immune response may operate best at intermediate GSH levels that are not too high to inhibit IL-2 production but sufficient to support DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208308     DOI: 10.1016/0008-8749(90)90292-y

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  9 in total

1.  The cathepsin B inhibitor z-FA-CMK induces cell death in leukemic T cells via oxidative stress.

Authors:  K Y Liow; Sek C Chow
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-10-31       Impact factor: 3.000

Review 2.  The glutathione system: a new drug target in neuroimmune disorders.

Authors:  Gerwyn Morris; George Anderson; Olivia Dean; Michael Berk; Piotr Galecki; Marta Martin-Subero; Michael Maes
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

3.  Dysregulation of plasma amino acid levels in HIV-infection and cancer and its relevance for the immune system.

Authors:  W Dröge; H P Eck; H Gmünder; S Mihm
Journal:  Amino Acids       Date:  1991-06       Impact factor: 3.520

Review 4.  Requirement for prooxidant and antioxidant states in T cell mediated immune responses.--Relevance for the pathogenetic mechanisms of AIDS?

Authors:  W Dröge; H P Eck; H Gmünder; S Mihm
Journal:  Klin Wochenschr       Date:  1991-12-15

5.  The systemic availability of oral glutathione.

Authors:  A Witschi; S Reddy; B Stofer; B H Lauterburg
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  A role of cellular glutathione in the differential effects of iron oxide nanoparticles on antigen-specific T cell cytokine expression.

Authors:  Chien-Chang Shen; Hong-Jen Liang; Chia-Chi Wang; Mei-Hsiu Liao; Tong-Rong Jan
Journal:  Int J Nanomedicine       Date:  2011-11-08

Review 7.  T cells and reactive oxygen species.

Authors:  Aleksey V Belikov; Burkhart Schraven; Luca Simeoni
Journal:  J Biomed Sci       Date:  2015-10-15       Impact factor: 8.410

8.  Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism.

Authors:  Shannon Rose; Stepan Melnyk; Timothy A Trusty; Oleksandra Pavliv; Lisa Seidel; Jingyun Li; Todd Nick; S Jill James
Journal:  Autism Res Treat       Date:  2011-11-24

9.  Role of Glutathione Conjugation in 1-Bromobutane-induced Immunotoxicity in Mice.

Authors:  Sang Kyu Lee; Dong Ju Lee; Tae Won Jeon; Gyu Sub Ko; Se Hyun Yoo; Hyun Woo Ha; Mi Jeong Kang; Wonku Kang; Sang Kyum Kim; Tae Cheon Jeong
Journal:  Toxicol Res       Date:  2010-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.